Unithiol 250mg/5ml solution for injection ampoules
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Unithiol
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 4 · 1958–2026
Showing the 50 most relevant studies, sorted by most relevant.
Monica Carnovale, Davide Lonati, Azzurra Schicchi, et al.
Clinical Toxicology, 2023
- Unithiol
- Acetylcysteine
- Cobalt
V.V. Gordienko, R.B. Kosuba, O.O. Perepelytsya, et al.
Clinical and experimental pathology, 2022
Aim – to analyze and summarize the published information related to experimental andtherapeutic results of Unithiol application in Ukraine.Conclusion. As seen from the analysis of experimental and therapeutic results, furtherextended investigation of the pharmacodynamics of Unithiol seems reasonable in thelight of its effective administration as an antidote, and as a metabolitotropic drug in thetherapy of other pathological conditions.
Abstract licence: CC BY-NC-SA 4.0
Michael Abouyannis, Yvonne K. Nyambura, Samson Ngome, et al.
eBioMedicine, 2025
- Snake Bites
- Kenya
- Healthy Volunteers
Daniela Pelclova, Karel Lach
Clinical Toxicology, 2023
- Unithiol
- Acetylcysteine
- Cobalt
P. D. Kuznetsova, E. A. Mukhanova, A. A. Tereshchenko, et al.
Nanobiotechnology Reports, 2024
Reactions Weekly, 2024
Reactions Weekly, 2023
A. O. Prituzhalova, T. I. Kuzmina
International Journal of Veterinary Medicine, 2026
Michael Abouyannis, Yvonne K. Nyambura, Samson Ngome, et al.
2024
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.